share_log

东北制药(000597.SZ):获得维格列汀片的药品注册证书

Northeast Pharmaceutical Group (000597.SZ) has obtained the pharmaceutical registration certificate for Vigilantin tablets.

Gelonghui Finance ·  Jul 8 06:48

On July 8th, Gelunhui revealed that its subsidiary, Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. received a Drug Registration Certificate (Acceptance Number: CYHS2202151, Certificate Number: 2024S01432) approved and issued by the National Medical Products Administration for Voglibose Tablets.

The original manufacturer of Voglibose Tablets is Novartis AG, and its domestic product name is 'Jiaweile'. Voglibose Tablets are used to treat Type 2 diabetes.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment